These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19712557)

  • 21. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
    Mak A; Cheung MW; Cheak AA; Ho RC
    Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
    Fawzy M; Shokeir T; El-Tatongy M; Warda O; El-Refaiey AA; Mosbah A
    Arch Gynecol Obstet; 2008 Jul; 278(1):33-8. PubMed ID: 18071727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
    Naru T; Khan RS; Ali R
    East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
    Ismail AM; Hamed AH; Saso S; Abu-Elhasan AM; Abu-Elghar MM; Abdelmeged AN
    Int J Gynaecol Obstet; 2016 Feb; 132(2):219-23. PubMed ID: 26810338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of pregnant patients with antiphospholipid syndrome.
    Cervera R; Balasch J
    Lupus; 2004; 13(9):683-7. PubMed ID: 15485103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
    Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid syndrome in obstetrics.
    Kemp M; Thomas W
    Lupus; 2018 Oct; 27(1_suppl):28-31. PubMed ID: 30452326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Farquharson RG; Quenby S; Greaves M
    Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome.
    Di Nisio M; Peters L; Middeldorp S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004734. PubMed ID: 15846729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of miscarriage in antiphospholipid syndrome.
    Passaleva A; Massai G; D'Elios MM; Livi C; Abbate R
    Autoimmunity; 1992; 14(2):121-5. PubMed ID: 1303678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspirin and antiphospholipid syndrome].
    Hachulla E; Piette AM; Hatron PY; Blétry O
    Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.
    Botet F; Romera G; Montagut P; Figueras J; Carmona F; Balasch J
    J Perinat Med; 1997; 25(2):192-6. PubMed ID: 9189840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome and recurrent miscarriage.
    Rai RS
    J Postgrad Med; 2002; 48(1):3-4. PubMed ID: 12082317
    [No Abstract]   [Full Text] [Related]  

  • 38. [Low dose of aspirin during pregnancy].
    Aguilera C; Agustí A
    Med Clin (Barc); 2007 Jan; 128(1):31-3. PubMed ID: 17266890
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
    Menashe Y; Ben-Baruch G; Greenspoon JS; Carp HJ; Rosen DJ; Mashiach S; Many A
    J Reprod Med; 1993 Aug; 38(8):625-9. PubMed ID: 8410869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
    Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
    N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.